Bioventus (BVS) Market Capitalization (2021 - 2026)

Bioventus (BVS) has reported Market Capitalization for 6 consecutive years, with $821.5 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Market Capitalization rose 46.78% year-over-year to $821.5 million; the trailing twelve-month figure through Jun 2026 stood at $821.5 million (up 46.78% YoY), and the FY2025 full-year result was $616.7 million, down 27.98% from the prior year.
• Market Capitalization grew to $821.5 million in Q2 2026 per BVS's latest filing, from $745.8 million in the prior quarter.
• Across five years, Market Capitalization topped out at $1.1 billion in Q2 2022 and bottomed at $83.8 million in Q2 2023.
• Historically, Market Capitalization has averaged $558.4 million across 5 years, with a median of $550.9 million in 2022.
• The sharpest annual moves came in 2023 and 2024: Market Capitalization tumbled 92.03% in 2023, then soared 394.17% in 2024.
• Over 5 years, Market Capitalization stood at $203.2 million in 2022, then soared by 105.04% to $416.6 million in 2023, then soared by 105.52% to $856.2 million in 2024, then declined by 27.98% to $616.7 million in 2025, then surged by 33.22% to $821.5 million in 2026.
• According to Business Quant data, Market Capitalization over the past three periods registered $821.5 million, $745.8 million, and $616.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.